Facebook
X
LinkedIn
ForwardBridging the Gap: Applying the AMCP Real-World Evidence (RWE) Standards to Facilitate Communication Between Manufacturers and Payers
Pricing: Free for Members and $30 for Non-Members
Course Description
Real-world evidence (RWE), generated from real-world data (RWD), has great potential in expanding the totality of evidence to bridge the gap between research and clinical care. The AMCP Research Institute launched the RWE Initiative to develop a set of RWE standards to facilitate efficient communication and ensure that RWE produced by pharmaceutical manufacturers meets the expectations and needs of payers and formulary decision-makers throughout the drug product life cycle. Through an interactive panel discussion, attendees will learn how to apply the AMCP RWE Standards from both the RWE producer (e.g., pharmaceutical company) and RWE user (e.g., payer) perspectives. Panelists will apply the Standards to a real-world use case and demonstrate how they can facilitate two-way communication around RWE. Participants will learn practical approaches to obtaining RWE, assessing study quality, interpreting findings, and gain a comprehensive understanding of how to use the AMCP RWE Standards to inform strategic decision-making.
Target Audience
Pharmacists who practice in managed care settings.
Learning Objectives
At the completion of this activity, participants should be able to:
- Describe the elements of the AMCP RWE Standards, developed through multi-stakeholder consensus, and how the Standards support the AMCP Dossier.
- Recognize how to assess and interpret different types of RWE and how they may be used in payer or formulary decision-making.
- Discuss how to apply the AMCP RWE Standards from the RWE producer (e.g., pharmaceutical company) and RWE user (e.g., payer) perspectives to support two-way communication and incorporation into payer decision processes.
Cate Lockhart, PharmD, PhD
Chief Science Officer & Executive Director
AMCP & BBCIC
Alexandria, VA
Dana McCormick, RPh
Director
AMCP
Grapevine, TX
Elizabeth Powers, MBA
VP & GM, Regulatory Science and Study Innovation
IQVIA Inc.
New York, NY
Brian Sweet, BS Pharm, MBA
Executive Director, Health Economics & Outcomes Research
Geron
Naples, FL
Disclosures
| Faculty/Reviewer/Planner | Reported Relevant Financial Relationships |
| Cate Lockhart Faculty | Disclosed no relevant financial relationships. |
| Dana McCormick Faculty | Disclosed no relevant financial relationships. |
| Elizabeth Powers Faculty | Employee: IQVIA Inc; Individual Stocks/Stock Options: IQVIA Inc |
| Brian Sweet Faculty | Employee: Bristol-Myers Squibb and Geron. |
| Tracy McDowd Peer Reviewer | Disclosed no relevant financial relationships. |
| Brooke Whittington Planner | Disclosed no relevant financial relationships. |
The Academy of Managed Care Pharmacy (AMCP) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
ACPE UAN: 0233-0000-25-042-H04-P • Activity Type: Knowledge-Based
Contact Hours: 1.25
Release Date: December 5, 2025 • Expiration Date: December 31, 2026
Activity Fee: Free for Members and $30 for Non-Members
Participants should claim continuing pharmacy education (CPE) credit for this home study activity only if they have not claimed credit for the live activity presented at Nexus 2025. CPE credit will be processed through the AMCP Learn portal and reported directly to CPE Monitor. Please allow 72 hours for processing and posting in your NABP account.
To receive credit for an online activity you must:
- Review the full content of the activity.
- Successfully complete the post-test (required to pass with a score of 70% or higher, it may be taken a maximum of three times).
- Complete a specific activity evaluation.
Available Credit
- 1.25 ACPEThe Academy of Managed Care Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.